Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN7000 in Chronic Hepatitis C
NCT00352235Phase 2Completed
- Sponsor
- Foundation for Liver Research
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-galactosylceramide in hepatitis C (HCV), sponsored by Foundation for Liver Research. Started Aug 2003; status: completed.
02
Drugs
alpha-galactosylceramide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00352235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352235.